Walleye Capital LLC Edwards Lifesciences Corp Put Options Transaction History

Walleye Capital LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $1.89 Million - $2.11 Million	-22,400 Reduced 32.32%	46,900 $4.33 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $1.41 Million - $1.86 Million	-19,500 Reduced 21.96%	69,300 $6.62 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $3.1 Million - $3.91 Million	50,300 Added 130.65%	88,800 $6.77 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $741,296 - $999,166	10,700 Added 38.49%	38,500 $2.67 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $2.26 Million - $2.61 Million	27,700 Added 27700.0%	27,800 $2.62 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $7,426 - $8,451	100 New	100 $8,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $947,255 - $1.23 Million	11,500 New	11,500 $950,000
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $6,155 - $7,543	-100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $5,574 - $6,441	-100 Reduced 50.0%	100 $18,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $9,578 - $12,810	200 New	200 $38,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.